Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, May 12, 2022, at 5:00 p.m. ET
CELEBRATION, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS:KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and commercialization of novel treatments for rare central nervous system (CNS) and neurodegenerative diseases, today reported its financial results for the first quarter ended March 31, 2022.
Read more at globenewswire.com